aca24@aca-pharma.de/

+49 341 33 73 33 60

Guideline on setting health based exposure limits…

Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/ CVMP/ SWP/169430/2012) has been become effective in June 2015.
Link: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/11/WC500177735.pdf

Requests on support are welcome.

 

Kommentare deaktiviert für Guideline on setting health based exposure limits… News

Read more